homeindia News‘Schools are non drivers of COVID transmission’, ICMR calls for school reopening

‘Schools are non-drivers of COVID transmission’, ICMR calls for school reopening

In a paper published in the Indian Journal of Medical Research, ICMR says global evidence suggests schools as ‘non-drivers’ of transmission of SARS-CoV-2 infection in the community. There is ample evidence to suggest that children aged 1-17 years have similar susceptibility to a mild form of SARS-CoV-2 infection as in adults, however, the risk of severe disease and mortality in children when compared to adults is much less.

By Archana Shukla  Sept 27, 2021 8:50:58 PM IST (Published)


"Schools need to be re-opened in a phased manner (beginning with primary schools followed by secondary schools) and allowed to remain open and safe with appropriate multi-layered mitigation measures," says India's premier medical body Indian Council of Medical Research.
In a paper published in the Indian Journal of Medical Research, ICMR says global evidence suggests schools as ‘non-drivers’ of transmission of SARS-CoV-2 infection in the community. There is ample evidence to suggest that children aged 1-17 years have similar susceptibility to a mild form of SARS-CoV-2 infection as in adults, however, the risk of severe disease and mortality in children when compared to adults is much less. Other factors to consider also is that there is less onward transmission of SARS-CoV-2 infection by younger children than older children and adults.
Since vaccination is the key to prevent severe disease, ICMR calls for prioritising vaccination for children above 12 years of age. "Available evidence suggests that children aged 12 years and above are at a high risk of contracting the infection and therefore must be prioritized for vaccination compared to the younger children." COVID-19 vaccine trials for children and adolescents are currently ongoing in India. Zydus Cadila vaccine that conducted trials on children above 12 years has been cleared by the regulator, however advisory on use on children is still awaited.